Postmenopausal osteoporosis

MD Walker, E Shane - New England Journal of Medicine, 2023 - Mass Medical Soc
Key Clinical Points Postmenopausal Osteoporosis Fragility fractures are very common
among postmenopausal women and are associated with increased morbidity, mortality, and …

UK clinical guideline for the prevention and treatment of osteoporosis

CL Gregson, DJ Armstrong, J Bowden, C Cooper… - Archives of …, 2022 - Springer
Abstract Summary The National Osteoporosis Guideline Group (NOGG) has revised the UK
guideline for the assessment and management of osteoporosis and the prevention of …

[HTML][HTML] The clinician's guide to prevention and treatment of osteoporosis

MS LeBoff, SL Greenspan, KL Insogna… - Osteoporosis …, 2022 - Springer
Osteoporosis is the most common metabolic bone disease in the USA and the world. It is a
subclinical condition until complicated by fracture (s). These fractures place an enormous …

The epidemiology of osteoporosis

MA Clynes, NC Harvey, EM Curtis… - British medical …, 2020 - academic.oup.com
Introduction With a worldwide ageing population, the importance of the prevention and
management of osteoporotic fragility fractures is increasing over time. In this review, we …

Update on osteoporosis screening and management

AK Anam, K Insogna - Medical clinics, 2021 - medical.theclinics.com
Osteoporosis is a metabolic bone disease characterized by low bone mass and
microarchitectural deterioration of the bone tissue, leading to reduced bone strength and …

Osteoporosis in men

T Vilaca, R Eastell, M Schini - The lancet Diabetes & endocrinology, 2022 - thelancet.com
Osteoporosis in men is a common but often overlooked disorder by clinicians. The criterion
for osteoporosis diagnosis in men is similar to that in women—namely, a bone mineral …

Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline

R Eastell, CJ Rosen, DM Black… - The Journal of …, 2019 - academic.oup.com
Objective The objective is to formulate clinical practice guidelines for the pharmacological
management of osteoporosis in postmenopausal women. Conclusions Evidence from …

Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS

E Tsourdi, MC Zillikens, C Meier, JJ Body… - The Journal of …, 2021 - academic.oup.com
Context Denosumab discontinuation is characterized by an increase in bone turnover
overriding pretreatment status, a rapid bone loss in the majority and multiple vertebral …

Menopausal osteoporosis: screening, prevention and treatment

EL Yong, S Logan - Singapore medical journal, 2021 - pmc.ncbi.nlm.nih.gov
Screening for osteoporosis in women can be based on age and weight, using the
Osteoporosis Screening Tool for Asians and assessment for other risk factors such as early …

Osteoporosis treatment: recent developments and ongoing challenges

S Khosla, LC Hofbauer - The lancet Diabetes & endocrinology, 2017 - thelancet.com
Osteoporosis is an enormous and growing public health problem. Once considered an
inevitable consequence of ageing, it is now eminently preventable and treatable. Ironically …